01/30/2025
3:13 PM | Marriott Tina (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2025
4:09 PM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/15/2025
3:12 PM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/14/2025
3:21 PM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
4:26 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
8:04 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
9:58 AM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2025
9:30 AM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/06/2025
5:02 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
5:02 PM | Li Dean Y (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
5:02 PM | Dar Zavain (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for RXRX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Recursion Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
12/26/2024
3:24 PM | Marriott Tina (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2024
3:16 PM | Recursion Pharmaceuticals (Issuer)
Taylor Ben R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
5:49 PM | Recursion Pharmaceuticals (Issuer)
Taylor Ben R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
4:05 PM | Recursion Pharmaceuticals (Filer)
| Form 424B7 | |
12/17/2024
4:06 PM | Recursion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/11/2024
3:48 PM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2024
4:46 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
9:29 AM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/04/2024
9:32 AM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/03/2024
3:40 PM | Recursion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/02/2024
6:02 PM | Recursion Pharmaceuticals (Issuer)
Taylor Ben R (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/27/2024
3:09 PM | Recursion Pharmaceuticals (Filer)
| Form 8-K/A | |
11/26/2024
3:48 PM | Recursion Pharmaceuticals (Filer)
| Form 8-K/A | |
11/22/2024
5:25 PM | Michor Franziska (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/22/2024
5:25 PM | Michor Franziska (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2024
6:11 AM | Recursion Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/20/2024
6:14 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/19/2024
5:26 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
5:26 PM | Marriott Tina (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
5:26 PM | Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
5:26 PM | Mauro David J (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2024
5:52 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
6:19 PM | Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
6:19 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
3:34 PM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/13/2024
9:11 AM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/13/2024
8:22 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
3:57 PM | Recursion Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/12/2024
1:48 PM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/12/2024
9:34 AM | FMR LLC (Filed by)
Recursion Pharmaceuticals (Subject)
| Form SC 13G/A | |
Elon’s #1 AI Stock” SET TO SOAR (Ad) Forget ChatGPT!
Because Elon Musk's AI promises to be 100x more powerful. Get all the details here >>> |
11/08/2024
1:17 PM | BlackRock, Inc. (Filed by)
Recursion Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/06/2024
3:18 PM | Recursion Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
5:05 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
5:12 AM | Recursion Pharmaceuticals (Filer)
| Form DEFA14A | |
11/04/2024
3:16 PM | Kinnevik AB (0001766574) (Filed by)
Recursion Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/04/2024
12:27 PM | Recursion Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024
8:46 AM | BAILLIE GIFFORD & CO (Filed by)
Recursion Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
10/31/2024
5:01 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
4:20 PM | Recursion Pharmaceuticals (Filer)
| Form DEFA14A | |
10/29/2024
3:35 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/28/2024
4:25 PM | Marriott Tina (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/24/2024
3:22 PM | Marriott Tina (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/22/2024
2:24 PM | BlackRock, Inc. (Filed by)
Recursion Pharmaceuticals (Subject)
| Form SC 13G/A | |
10/18/2024
9:59 AM | Recursion Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
10/17/2024
4:27 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/17/2024
4:15 PM | Burrell Terry-Ann (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/15/2024
3:42 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/10/2024
5:40 PM | Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2024
5:00 AM | Recursion Pharmaceuticals (Filer)
| Form DEFM14A | |
10/09/2024
3:23 PM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/08/2024
3:19 PM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/04/2024
5:29 PM | Li Dean Y (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
5:30 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
5:30 PM | Dar Zavain (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
5:30 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
3:58 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
9:27 AM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2024
12:31 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2024
7:03 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/01/2024
1:20 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/30/2024
5:15 PM | Marriott Tina (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/26/2024
3:14 PM | Marriott Tina (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/19/2024
4:48 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2024
3:27 PM | Recursion Pharmaceuticals (Filer)
| Form DEFA14A | |
09/17/2024
5:03 AM | Recursion Pharmaceuticals (Filer)
| Form PREM14A | |
09/12/2024
5:28 PM | Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
4:15 PM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/10/2024
4:00 PM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/06/2024
3:57 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
4:25 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
10:43 AM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/04/2024
4:24 PM | Recursion Pharmaceuticals (Filer)
| Form DEFA14A | |
09/04/2024
12:16 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/03/2024
3:48 PM | Marriott Tina (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
3:27 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/03/2024
7:01 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/03/2024
7:02 AM | Recursion Pharmaceuticals (Filer)
| Form DEFA14A | |
08/30/2024
3:26 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
3:53 PM | Marriott Tina (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/28/2024
3:49 PM | Recursion Pharmaceuticals (Filer)
| Form DEFA14A | |
Is this Elon’s true agenda? (Ad) All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors have all turned to my business partner and I for our thoughts on the market. And with every investor in America wondering what Elon is going to do now that he's in Washington, this is what we tell them Click here for my report |
08/27/2024
3:10 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
3:42 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2024
4:25 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
5:48 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:25 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024
6:09 PM | Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
6:09 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
6:09 PM | Mauro David J (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
6:09 PM | Marriott Tina (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
